1 Min Read
* DELCATH ANNOUNCES PRELIMINARY SAFETY ANALYSIS FOR PHASE 3 FOCUS TRIAL
* DELCATH SYSTEMS INC - DSMB HAS RECOMMENDED THAT STUDY CONTINUE WITHOUT MODIFICATION Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.